Next Article in Journal
Rapidly Declining SARS-CoV-2 Antibody Titers within 4 Months after BNT162b2 Vaccination
Next Article in Special Issue
Safety Profile of Recommended Vaccinations in Adolescents: Data from Surveillance of Adverse Events Following Immunization in Puglia (Italy), 2016–2020
Previous Article in Journal
Blocking HIF to Enhance NK Cells: Hints for New Anti-Tumor Therapeutic Strategies?
Previous Article in Special Issue
First Dose of the BNT162b2 mRNA COVID-19 Vaccine Reduces Symptom Duration and Viral Clearance in Healthcare Workers
 
 
Article

Article Versions Notes

Vaccines 2021, 9(10), 1143; https://doi.org/10.3390/vaccines9101143
Action Date Notes Link
article pdf uploaded. 7 October 2021 17:32 CEST Version of Record https://www.mdpi.com/2076-393X/9/10/1143/pdf-vor
article pdf uploaded. 8 October 2021 10:53 CEST Updated version of record https://www.mdpi.com/2076-393X/9/10/1143/pdf-vor
article xml file uploaded 13 October 2021 11:47 CEST Original file -
article xml uploaded. 13 October 2021 11:47 CEST Update -
article pdf uploaded. 13 October 2021 11:47 CEST Updated version of record https://www.mdpi.com/2076-393X/9/10/1143/pdf-vor
article html file updated 13 October 2021 11:48 CEST Original file -
article xml file uploaded 22 October 2021 08:06 CEST Update -
article xml uploaded. 22 October 2021 08:06 CEST Update -
article pdf uploaded. 22 October 2021 08:06 CEST Updated version of record https://www.mdpi.com/2076-393X/9/10/1143/pdf-vor
article html file updated 22 October 2021 08:07 CEST Update -
article pdf uploaded. 19 November 2021 03:27 CET Updated version of record https://www.mdpi.com/2076-393X/9/10/1143/pdf
article xml uploaded. 19 November 2021 03:27 CET Update https://www.mdpi.com/2076-393X/9/10/1143/xml
article html file updated 19 November 2021 03:28 CET Update https://www.mdpi.com/2076-393X/9/10/1143/html
Back to TopTop